Combining the power of nature and genomics to create new medicines

The Demuris Portfolio

Programme Primary Hit Confirmed novel Hit Lead Lead optimization Candidate Patent status
Gram positive antibiotics
DC355/B1. Resistant TB and Gonorrohea Patented
DC355/A, DC701/A. Novel RNAP inhibitor In draft
Backup: > 2,000 Hits
Cancer (AML)
DC859/A. FOXO1/3 inhibitor In draft
Gram negative antibiotics
Three known compounds with potential for novel IP
Backup: ~ 160 Hits
DC066/A. Novel cell wall active compound
Backup: > 600 Hits

Demuris Limited
Newcastle Biomedicine Bio-Incubators,
Faculty of Medical Sciences, Framlington Place,
Newcastle upon Tyne, NE2 4HH, UK

Tel: +44 (0)191 223 5608
Fax: +44 (0)191 223 5609

Demuris Limited is registeD7CF33 in England, company number: 06255507

Demuris Limited 2015